Histogen's FINAL Phase I/IIa Results (2013)
Collapse
X
-
Who knows what this could do combined with other treatments though....
and at least we got good news about Replicel this week.Comment
-
Well replicel just found a (huge) investor, throwing money at them, so at least this investor sees some possibility of their trial II becoming a success. And don't forget Jahoda et al succeeded recently at biogenerating a human hair follicle and have it grow on human skin. So Histogen most definately wasn't the only one to bring hope. But yeah, agreed, it still sucks hard.Comment
-
Is it not just the temporal regrowth that's rubbish (5%)? The rest doesn't seem too bad. And I don't really respond well to fin and minox so this wouldn't be too bad for meComment
-
If this treatment could be given twice a year without comprimising health (so no adverse effect on hemoglobine) AND the treatable size of the scalp would be big enough (again without effecting hemoglobine), then yeah, this could be something. But even then, visiting their clinic twice a year, for pretty marginal results, would still suck. And would indeed also be quite a drain of money.Comment
-
I'm coming round to Iron Man's way of thinking that developments in hair transplant technology (whether by Gho, Nigam or whomever) is our best bet. However that's not too useful for us Nw2s with diffuse loss.
Possibly our only other hope is resarch into treatments involving Prostaglandins, and hoping that the non-success that forum-going experimenters have had so far is because of amateur cluelessness.Comment
-
If this treatment could be given twice a year without comprimising health (so no adverse effect on hemoglobine) AND the treatable size of the scalp would be big enough (again without effecting hemoglobine), then yeah, this could be something. But even then, visiting their clinic twice a year, for pretty marginal results, would still suck. And would indeed also be quite a drain of money.
What happens now then? Will they conduct further trials?
They haven't released any new patient photos. I wonder if someone here wants to contact Histogen to quiz them about results and photos, and the next steps taken...Comment
-
With anaemia as a potential danger, it is something that I would never try.Comment
-
few questions:
1. this was only the safety trial correct? couldn't things be much improved in the next dose range trial?
2. We still dont know how well this will work with a DHT inhibitor, which may help things out alot!
3. are there any pictures of patients here? would give us a little better of an idea than just statistics.Comment
-
1. this was only the safety trial correct? couldn't things be much improved in the next dose range trial?
3. are there any pictures of patients here? would give us a little better of an idea than just statistics.Comment
-
The past year or so has been very deflating for future hair loss treatments. Replicel, Histogen, and Aderans have all presented mediocre results without showing any significant cosmetic improvement. It's a shame but the situation looks much more bleak now than it did a few years ago when things were quite a bit more optimistic.
There are plenty of people studying hair loss treatments though and my bet is that a promising treatment will come from a source we aren't expecting.Comment
-
The past year or so has been very deflating for future hair loss treatments. Replicel, Histogen, and Aderans have all presented mediocre results without showing any significant cosmetic improvement. It's a shame but the situation looks much more bleak now than it did a few years ago when things were quite a bit more optimistic.
There are plenty of people studying hair loss treatments though and my bet is that a promising treatment will come from a source we aren't expecting.Comment
-
That's what they said but to me it seems just a part of the negotiations strategy. If they'd admit they were broke, finding an investor would even be more difficult (since its power over Histogen would be bigger).
HSC has adverse effect on Hemoglobin count, so upping the dose seems out of the question. In fact, one could wonder what part of the scalp could be treated without adversely effecting hemoglobin count. Maybe only a small part of the scalp could be treated ?
but the safety tihng is interesting, in this trial they only used 8 injections which is a tiny area of the scalp, so just to clarify, you cant get more than 8 injections say every 6 months? Could they raise the dose in those 8 injections? cause that's like just covering one area, would take two years to cover your head!Comment
Comment